Drug Details
General Information of the Drug (ID: DR3651) | ||||
---|---|---|---|---|
Name |
Micafungin
|
|||
Synonyms |
Micafungin; Mycamine; 235114-32-6; UNII-R10H71BSWG; Micafungin [INN]; CHEBI:600520; R10H71BSWG; Micafungin (INN); Mycamine(TM); FK463; CHEMBL457547; SCHEMBL11893279; C56H71N9O23S; Pneumocandin A0, 1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(4-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl]-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-; BDBM50478216; DB01141; X7260; D08218; Z-3191; 114M326; J-015136; Q6827850; [5-[(1S,2S)-2-[[(1R)-3-amino-1-hydroxy-3-oxo-propyl]-tetrahydroxy-[(1R)-1-hydroxyethyl]-methyl-hexaoxo-[[4-[5-(4-pentoxyphenyl)isoxazol-3-yl]benzoyl]amino][?]yl]-1,2-dihydroxy-ethyl]-2-hydroxy-phenyl] hydrogen sulfate; 5.1:6-anhydro{(4R,5R)-4,5-dihydroxy-N(2)-(4-{5-[4-(pentyloxy)phenyl]isoxazol-3-yl}benzoyl)-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-(3S,4S)-3-hydroxy-4-methyl-L-proline}
Click to Show/Hide
|
|||
Molecular Type |
Small molecule
|
|||
Disease | Candidosis [ICD-11: 1F23] | Approved | [1] | |
Structure |
![]() |
Click to Download Mol2D MOL |
||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
Formula |
C56H71N9O23S
|
|||
PubChem CID | ||||
Canonical SMILES |
CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O
|
|||
InChI |
1S/C56H71N9O23S/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85)/t25-,26+,31+,34-,35-,37+,38+,42-,43-,44-,45-,46-,47-,48-,52+/m0/s1
|
|||
InChIKey |
PIEUQSKUWLMALL-YABMTYFHSA-N
|
|||
CAS Number |
CAS 235114-32-6
|
|||
ChEBI ID | ||||
TTD Drug ID | ||||
DrugBank ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Farnesol | Mosla chinensis | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | Candida parapsilosis isolates | Microorganism model | Candida parapsilosis | |||
Candida parapsilosis ATCC 22019 | Microorganism model | Candida parapsilosis | ||||
Experimental
Result(s) |
Caspofungin and micafungin in combination with farnesol showed synergistcant interaction against Candida parapsilosis biofilms. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Fungal 1,3-beta-glucan synthase (Fung GSC2) | Molecule Info | [3] | |
KEGG Pathway | Starch and sucrose metabolism | Click to Show/Hide | ||
2 | MAPK signaling pathway - yeast |
